Bi-weekly Chemotherapy of Paclitaxel and Cisplatin in Patients with Metastatic or Recurrent Esophageal Cancer

Although various combinations of chemotherapy regimens have been tried for patients with esophageal cancer, their duration of survival is extremely poor. In this study, we investigated the safety and clinical efficacy of paclitaxel and cisplatin chemotherapy in metastatic or recurrent esophageal can...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Sang-Hee, Chung, Ik-Joo, Song, Sang-Yun, Yang, Deok-Hwan, Byun, Jeong-Rae, Kim, Yeo-Kyeoung, Lee, Je-Jung, Na, Kook-Joo, Kim, Hyeoung-Joon
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2005
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782158/
https://www.ncbi.nlm.nih.gov/pubmed/16100454
http://dx.doi.org/10.3346/jkms.2005.20.4.618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782158/
https://www.ncbi.nlm.nih.gov/pubmed/16100454
http://dx.doi.org/10.3346/jkms.2005.20.4.618

Ejemplares similares